Filed with ASX · · 3 pages · English
LTR Pharma Limited has appointed Nick Bell as Strategic Adviser to enhance its digital health and commercial growth initiatives. Bell, a prominent entrepreneur and digital-growth specialist, will focus on developing commercial opportunities within LTR Pharma's men's-health portfolio. His initial activities will involve connecting with telehealth platforms and evaluating patient-access pathways for the company's products. LTR Pharma's Executive Chairman highlighted Bell's extensive experience in building businesses and his potential to strengthen the company's digital health strategy.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
LTR Pharma Appoints Entrepreneur Nick Bell as Strategic Adviser to Support Digital Health and Commercial Growth 04 November 2026 Highlights • Prominent Australian entrepreneur, investor and digital-growth specialist Nick Bell appointed Strategic Adviser. • Appointment strengthens LTR Pharma’s...
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma